Fellowship of American Association of Pharmaceutical Scientists for Professor David Brayden
Posted: November 20, 2017
The American Association of Pharmaceutical Scientists (AAPS) has elected Professor David Brayden as a Fellow. He is the first Irish scientist to be conferred with this honour.
The AAPS elevates a few members to Fellow each year in recognition of their professional excellence in fields relevant to the Association’s mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
Fellows are nominated by supporters, selected by a committee of their peers and elevated by the AAPS Executive Council.
He is also co-lead Principal Investigator of Science Foundation Ireland’s Centre for Medical Devices (CURAM).
Professor Brayden has spent over 25 years in drug delivery research. He also worked for 10 years as a senior scientist at Elan Corporation before moving to UCD in 2001.
His research focuses on how to deliver poorly permeable macromolecules across the intestinal epithelium in order to guide formulation of oral dosage forms.
Large molecules, such as macromolecules, cannot easily pass through biological barriers such as epithelial tissues – tissues that line the surfaces and cavities of vessels and organs in the body.
Professor Brayden’s work involves devising solutions to make the macromolecules in oral drug doses pass more easily across the gut barrier.
He has published over 200 peer-reviewed articles of which 10 have been cited over 100 times as author or co-author. He is also a Fellow of the Controlled Release Society and was recently elected to the EU Academy of Sciences.
By: Jamie Deasy, digital journalist, UCD University Relations